Urethral Stricture Treatment Devices Market Insights & Dynamics:
The urethral stricture treatment devices market is observing a surge in product demand due to plethora of reasons with one of them being the rising prevalence of various cancers specifically in the pelvic region such as colorectal and prostate cancers. As per the data cited by the World Health Organization (WHO), in 2020, cancer of the colon and rectum were the third-most common cancer type globally and accounted for 1.93 million new cases.
Urethral Stricture Treatment Devices Market Size
In the same factsheet by the WHO, in 2020, prostate cancer was the fourth most prevalent cancer type globally and accounted for 1.41 million new cases. Urethral strictures have been associated as a complication of radiation treatment for prostate and rectal cancers, surgery for an enlarged prostate or prostate cancer, or trauma to the genitals or perineum. It has been established in various studies that radiation therapy for cancer treatment, particularly prostate cancer, leads to reduced vascularity around the treatment area.
Furthermore, the risk for developing urethral strictures appear to enhance further in patient receiving both the brachytherapy and external beam radiation therapy. Additionally, it has also been reported that radial prostatectomy also significantly increases the chances of the formation of urethral strictures thereby indicating that treatment of cancers in the pelvic region may result in the formation of urethral strictures.
Therefore, the rising prevalence of cancers in the pelvic
region may result in the increased incidence of urethral strictures which in
turn may drive the demand for urethral strictures treatment devices ultimately
driving the urethral strictures treatment devices market during the forecast
period (2021-2026).
Read for more information about Urethral Stricture Treatment Devices Market Forecast
Also read-
Comments
Post a Comment